Relational Intelligence
Should We Slow Down AI?
AI can help us outgrow the systems that make life insecure. A deep look at what we'd be protecting by slowing down, and what we stand to gain by letting go of our need to control.
The Century Report
KRAS Drug Cracks Pancreatic Cancer - TCR 05/09/26
The 20-Second Scan * Researchers reported in the New England Journal of Medicine that an experimental drug targeting a family of mutant KRAS proteins extended survival in patients with deadly pancreatic cancer in a small clinical trial. * Washington state's Peninsula school district said it expects to save approximately $220,
The Century Report
AI Finds Natural Ozempic - TCR 04/13/26
The 20-Second Scan * Stanford researchers used AI to identify a naturally occurring peptide called BRP that reduced appetite and body fat in animal studies without the nausea, constipation, or muscle loss associated with semaglutide. * A separate Stanford study found that roughly 10% of the population carries genetic variants conferring "
The Century Report
Anthropic Buys Biology - TCR 04/04/26
The 20-Second Scan * Anthropic acquired biotech startup Coefficient Bio in a $400 million stock deal, bringing a 10-person drug discovery team into its health and life sciences division. * Microsoft released three in-house AI models for transcription, voice generation, and image creation, built by Mustafa Suleyman's superintelligence team and
The Century Report
Lilly Bets $2.75B on AI - TCR 03/30/26
The 20-Second Scan * Eli Lilly signed a $2.75 billion deal with Hong Kong-based Insilico Medicine to bring AI-discovered drugs to the global market, with 28 compounds developed using generative AI and nearly half already in clinical stages. * A construction robot completed 100 megawatts of solar installation at the AES
The Century Report
TCR 03/23/26: Batteries Built in Months
The 20-Second Scan * Earendil Labs raised $787 million backed by Sanofi and Pfizer for its AI-driven biologics platform, which has generated more than 40 drug programs including an anti-TL1A antibody entering Phase 2. * U.S. grid battery manufacturing capacity reached self-sufficiency for the first time, with domestic factories now able